Learn More
Description
- Sodium Valproate is reported to cause inositol depletion, activate the ERK pathway, inhibit GSK-3 α and GSK-3β
- Valproic Acid has been reported to be a potent inhibitor of HDAC (histone deacetylase) in vitro (IC50 = 400μM for HDAC1), thereby relieving HDAC-dependent transcriptional repression and causes the hyperacetylation of histones in cultured cells
- In animal studies, Valproic Acid has been observed to reduce tumor growth and metastasis formation
- Valproic Acid is reported to activate Wnt-dependent gene expression and to mimic trichostatin A in the inhibition of histone deacetylase
- This compound is also an inhibitor of the CYP2C9 enzyme
- Anti-convulsant that also has efficacy as a mood stabilizer in bipolar disorder
Specifications
Specifications
| Color | White |
| Packaging | Glass |
| Quantity | 100 g |
| Percent Purity | 100.8 |
Safety and Handling
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.